In this video


FDA panel rejects Pfizer's Covid booster for the general public

An influential Food and Drug Administration advisory committee on Friday resoundingly rejected a plan to administer booster shots of Pfizer and BioNTech's Covid-19 vaccine to the general public, saying they needed more data. However, the panel did unanimously recommend the third shot for those 65 and older, and those at higher risk of infection.
Fri, Sep 17 20214:38 PM EDT